Evidence map›Paper›PMID 27843542›Full record

ArticleWorld journal of radiology2016

Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art.

Federico Caobelli, Laura Evangelista, Natale Quartuccio, Demetrio Familiari, Corinna Altini, Angelo Castello, Mariapaola Cucinotta, Rossella Di Dato, Cristina Ferrari, Aurora Kokomani and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in World journal of radiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. EANM/SNMMI guideline/procedure standard for [European journal of nuclear medicine and molecular imaging · 2025
    Guideline
  2. Nuclear medicine and molecular imaging · 2025
    Article
  3. Granzyme B PET Imaging for Assessment of Disease Activity in Inflammatory Bowel Disease.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  4. Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  5. State of the art ofClinical and translational imaging · 2021
    Review
  6. Review
  7. Review
  8. Article
  9. Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Article
  10. Advances in Imaging Specific Mediators of Inflammatory Bowel Disease.International journal of molecular sciences · 2018
    Review
  11. Inflammatory bowel disease: towards a personalized medicine.Therapeutic advances in gastroenterology · 2018
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 11 institutions in 3 countries.

Federico CaobelliFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Laura EvangelistaFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Natale QuartuccioFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Demetrio FamiliariFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Corinna AltiniFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Angelo CastelloFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Mariapaola CucinottaFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Rossella Di DatoFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Cristina FerrariFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Aurora KokomaniFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Iashar LaghaiFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Riccardo LaudicellaFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Silvia MigliariFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Federica OrsiniFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Salvatore Antonio PignataFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Cristina PopescuFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Erinda PutaFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Martina RicciFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Silvia SeghezziFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Alessandro SindoniFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Martina SolliniFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Letterio SturialeFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Anna SvyridenkaFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Vittoria VerguraFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Pierpaolo AlongiFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
Young Aimn Working GroupFederico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.
University Hospital of Basel · CHUniversity of Parma · ITAzienda Ospedaliera Ospedale Maggiore · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITFondazione Istituto G. Giglio di Cefalù · ITIstituto Oncologico Veneto · ITOspedale Garibaldi · ITUniversity of Bari Aldo Moro · ITUniversity of Florence · ITUniversity of Manchester · GBUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo present the current state-of-the art of molecular imaging in the management of patients affected by inflammatory bowel disease (IBD).

methodsA systematic review of the literature was performed in order to find important original articles on the role of molecular imaging in the management of patients affected by IBD. The search was updated until February 2016 and limited to articles in English.

resultsFifty-five original articles were included in this review, highlighting the role of single photon emission tomography and positron emission tomography.

conclusionTo date, molecular imaging represents a useful tool to detect active disease in IBD. However, the available data need to be validated in prospective multicenter studies on larger patient samples.

Indexed as

18F-Fluorodehoxiglucose positron emission tomography/computed tomographyInflammationInflammatory bowel diseaseMolecular imagingWhite blood cell scintigraphy

Identifiers

PMID27843542
PMCPMC5084061
OpenAlexW2545196447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.